University Tunis El Manar

utm.rnu.tn

Total trials

69

Active

12

Phase 3

0

Total enrollment

6,870

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 7 of 7 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Ginger1
Adjustment of insulin doses DAR1
Adjustment of insulin doses CFT1
Dexamathsone 4mg/ml associated with experimental arm1
Intravenous Morphine1
Lidocaine IV1
Ketamine Injectable Solution1

Next readouts

  • 2026-02-10
  • 2026-03-01
  • 2026-06-30
  • 2026-06-30
  • 2026-08

Top conditions

  • Postoperative Pain6
  • Hypotension4
  • Anesthesia3
  • Adverse Effect3
  • Cesarean Section2
  • Labor Pain2
  • Anxiety2
  • Spinal Anesthesia2

Frequently asked questions about University Tunis El Manar

How many clinical trials does University Tunis El Manar have on ClinicalTrials.gov?
University Tunis El Manar is listed as the lead sponsor on 69 clinical trials in ClinicalTrials.gov, 12 of which are currently active (recruiting, enrolling, or ongoing).
How many of University Tunis El Manar's trials are in Phase 3?
0 of University Tunis El Manar's trials are in Phase 3, spread across 7 active drug programs.
What therapeutic areas does University Tunis El Manar focus on?
University Tunis El Manar's most-studied conditions on ClinicalTrials.gov are Postoperative Pain, Hypotension, Anesthesia, Adverse Effect, Cesarean Section.
When are University Tunis El Manar's next clinical trial readouts?
University Tunis El Manar has 5 upcoming primary-completion readouts tracked here; the soonest is “Comparison of Intravenous Lidocaine vs Ketamine in Colorectal Surgery”, expected around 2026-02-10.